SynOx Therapeutics raised an additional funding in a Series B extension led by Gilde Healthcare, bringing total capital to $92 million to support the Phase 3 TANGENT trial of emactuzumab.
Amount Raised
$92 Million
Round Type
Series B
DublinBiotechnologyHealth CareTherapeuticsInvestors
Description
SynOx Therapeutics Limited has announced the final close of its Series B financing, now totaling $92 million. The funding will support a registrational Phase 3 clinical trial for emactuzumab, targeting Tenosynovial Giant Cell Tumour.
Quick answer
SynOx Therapeutics raised $92 Million in a Series B round, dated October 30, 2024. Investors: Bioqube Ventures, Healthcap, Forbion and Gilde Healthcare. SynOx Therapeutics is based in Dublin, Dublin, Ireland.
- How much did SynOx Therapeutics raise?
- SynOx Therapeutics raised $92 Million in a Series B round on October 30, 2024.
- Who invested in SynOx Therapeutics?
- Bioqube Ventures, Healthcap, Forbion and Gilde Healthcare are named as investors in this round.
- What does SynOx Therapeutics do?
- SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications.
- Where is SynOx Therapeutics based and how big is it?
- SynOx Therapeutics is based in Dublin, Dublin, Ireland.
- Who are the decision-makers at SynOx Therapeutics?
- Fundz holds 2 contacts at SynOx Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as SynOx Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- BioSapien raised $5.5M (Series A) on December 13, 2024.
- East Ocyon Bio raised $4.2M (Seed) on December 11, 2024.
- Noema Pharma raised $147M (Series B) on December 11, 2024.
- Canton Strategic Holdings, Inc. raised $2M (Seed) on December 9, 2024.
- Alveron Pharma raised $5.3M (Seed) on December 6, 2024.
- Nuvig Therapeutics raised $161M (Series B) on December 5, 2024.
Who to call at SynOx Therapeutics, and when
A new round usually means SynOx Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SynOx Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SynOx Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SynOx Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SynOx Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSynOx Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.